Common Defects of ABCG2, a High-Capacity Urate Exporter, Cause Gout: A Function-Based Genetic Analysis in a Japanese Population
Hirotaka Matsuo(National Defense Medical College), Nariyoshi Shinomiya(National Institute of Infectious Diseases), Shin Tadokoro(National Defense Medical College), Yatami Asai(Seirei Social Welfare Community), Junichiro Nishiyama(Self-Defense Forces Central Hospital), Rieko Okada(Nagoya City University), Tappei Takada(University of Tokyo Hospital), Kenji Wakai(Japanese Society for Dialysis Therapy), Kousei Ito(Chiba University), Kimiyoshi Ichida(Tokyo University of Pharmacy and Life Sciences), Yuji Morimoto(Hokkaido University Hospital), Koji Suzuki(Hamamatsu University), Hiroki Inoue(National Defense Medical College), Yasuyoshi Kusanagi(National Defense Medical College), Kazuki Niwa(Toho University), Satoru Watanabe(National Defense Medical College), Masanori Fujita(University of Tokyo Hospital), Akiyoshi Nakayama(National Defense Medical College), Yuki Ikebuchi(University of Tokyo Hospital), Shigeaki Nonoyama(National Defense Medical College), Hideharu Domoto(Kure Medical Center), Nobuyuki Hamajima(Nagoya University), Asahi Hishida(Nagoya City University), Yutaka Sakurai(National Defense Medical College), Hiroshi Suzuki(University of Tokyo Hospital), Kazuko Nishio(Nagoya City University), Yoshikatsu Kanai(Open Society), Takahiro Nakamura(Kyoto University), Yuji Oikawa(Toho University), Keiko Kamakura(National Defense Medical College), Yuzo Takada(National Defense Medical College), Toshinori Chiba(National Defense Medical College), Tatsuo Hosoya(Jikei University School of Medicine), Mariko Naito(Nagoya City University)
Cited by 434
Related Papers
A Randomized Trial of Adjuvant Chemotherapy with Uracil–Tegafur for Adenocarcinoma of the Lung
|New England Journal of Medicine|2004|839
The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome
|Cell|1993|824
Decreased extra-renal urate excretion is a common cause of hyperuricemia
|Nature Communications|2012|690
Injection of Cultured Cells with a ROCK Inhibitor for Bullous Keratopathy
|New England Journal of Medicine|2018|551